CC’s transdisciplinary development team has created a way to democratise gene editing. This IP-free gene editing method avoids the timescales and costs involved with commercially licensing current CRISPR/Cas9 editing techniques.
Author profile
Dr Matthew Armean-Jones
Senior Consultant in Biotechnology and Bioinnovation
Matthew Jones is a Senior Consultant at Cambridge Consultants delivering projects for clients working at the interface between biotechnology and engineering.
Matthew is also supporting the development of our internal capabilities in cell free biology, laboratory automation and design of experiment approaches.
My insights
The next steps in harnessing biological computing for a sustainable future
What is biological computing, and what role will it play when looking to the sustainable technology of the future?
Harnessing biological computing for a sustainable future – Computing
This article by Matthew Armean-Jones and Aidong Xu examines the potential for biological computing to create more sustainable computing.